multiple sclerosis Archives - Iran News Daily https://irannewsdaily.com/tag/multiple-sclerosis/ Tue, 07 Sep 2021 12:52:22 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.4 https://irannewsdaily.com/wp-content/uploads/2020/04/cropped-iranlogo-32x32.png multiple sclerosis Archives - Iran News Daily https://irannewsdaily.com/tag/multiple-sclerosis/ 32 32 international congress on multiple sclerosis https://irannewsdaily.com/2021/09/international-congress-on-multiple-sclerosis/ https://irannewsdaily.com/2021/09/international-congress-on-multiple-sclerosis/#respond Tue, 07 Sep 2021 12:52:22 +0000 https://irannewsdaily.com/?p=132509 TEHRAN (Iran News) – The 18th International Congress on Multiple Sclerosis (MS) will be held virtually from December 1 to 3, ISNA reported on Sunday. The Iranian MS Society is to host the international MS congress with the cooperation of the MS research center of Tehran University of Medical Sciences, faculty members of medical universities, […]

The post international congress on multiple sclerosis appeared first on Iran News Daily.

]]> TEHRAN (Iran News) – The 18th International Congress on Multiple Sclerosis (MS) will be held virtually from December 1 to 3, ISNA reported on Sunday.

The Iranian MS Society is to host the international MS congress with the cooperation of the MS research center of Tehran University of Medical Sciences, faculty members of medical universities, and neurologists across the country.

The scientific event will be held in order to advance research and effective treatments for MS and to promote the scientific level of the Iranian medical community.

MS is one of the most common diseases in the central nervous system, that is, the brain and spinal cord. Multiple Sclerosis is an inflammatory demyelinating condition, which is caused by damage to myelin, a fatty material that insulates nerves.

According to the National Multiple Sclerosis Society, more than 2.8 million individuals suffer from neurological disease, which is found more in women than in men.

The total number of MS patients admitted by the Ministry of Health system all around the country has now reached above 70,000 people, which is an alarming number, Mehdi Shadnoush, head of the Health Ministry’s center for transplantation and disease management, said in May.

Stating that the prevalence of the disease is still 2.5 times higher in women than men and is developed more in the age group of 20 to 45 years, he noted that according to global statistics, the average prevalence is 112 people per 100,000 populations and its incidence is 5.2 per 100,000 populations. Of course, this ratio varies from country to country.

In Iran, every 87 per 100,000 populations are diagnosed with the disease, which is one of the countries with the highest prevalence rate, he added.

However, in recent decades, MS prevalence in Iran has grown larger than ever, especially in urban areas, he lamented, adding, so that the timely diagnosis and control of the disease among youth comes to attention more than ever.

On average, about 5,000 people develop MS in the country every year, according to Shadnoush.

The post international congress on multiple sclerosis appeared first on Iran News Daily.

]]> https://irannewsdaily.com/2021/09/international-congress-on-multiple-sclerosis/feed/ 0 Iran Unveils Rival Drug of Israeli MS Medication https://irannewsdaily.com/2020/09/iran-unveils-rival-drug-of-israeli-ms-medication/ https://irannewsdaily.com/2020/09/iran-unveils-rival-drug-of-israeli-ms-medication/#respond Thu, 17 Sep 2020 04:04:51 +0000 https://irannewsdaily.com/?p=117922 TEHRAN (Iran News) – A second Iranian pharmaceutical company has unveiled a special drug for treatment of multiple sclerosis (MS), saying it would rival a patented Israeli medication whose imports into Iran has been banned merely because of political reasons. Copamer is the brand name for a domestic version of glatiramer acetate, the medication vastly […]

The post Iran Unveils Rival Drug of Israeli MS Medication appeared first on Iran News Daily.

]]> TEHRAN (Iran News) – A second Iranian pharmaceutical company has unveiled a special drug for treatment of multiple sclerosis (MS), saying it would rival a patented Israeli medication whose imports into Iran has been banned merely because of political reasons.

Copamer is the brand name for a domestic version of glatiramer acetate, the medication vastly used to treat MS, Press TV reported on Wednesday.

The drug has been developed and manufactured by Zahravi Pharmaceuticals, a company based in the northwestern Iranian city of Tabriz.

A local health official said that Copamer would rival the patented version of glatiramer acetate currently marketed by Teva Pharmaceuticals, an American-Israeli pharmaceutical company based in the occupied Palestinian territories.

Teva has been struggling to maintain its monopoly over long-acting formulations of the drug despite repeated court actions by drug makers around the world to contest new patents obtained by the company.

“Currently this medication for MS is only produced in the world in Iran and (by) the Israeli regime,” said Mohammad Reza Siahi, an official from Tabriz University of Medical Sciences.

The active ingredient of Copamer is produced in Tehran, where Tofigh Daru, a major pharmaceutical company, announced in May that it had managed to develop a formulation to manufacture glatiramer acetate.

The CEO of Tofigh Daru said at the time that they developed the drug because Teva had refused to supply its patented medication to Iran merely because of political reasons.

Ya’ghub Haghighat Nia said that the injection drug would be much cheaper than its foreign versions once it reaches mass production in Iran.

He said the drug would generate millions of dollars in new revenues for Iran as the company plans to market it in countries like Turkey.

The post Iran Unveils Rival Drug of Israeli MS Medication appeared first on Iran News Daily.

]]> https://irannewsdaily.com/2020/09/iran-unveils-rival-drug-of-israeli-ms-medication/feed/ 0